Preventive Medicine Doctors in Fredericksburg, VA Accepting Medicare

3 Preventive Medicine doctors found. Showing 1 - 3

Richard Stuart Williams, MD Preventive Medicine - Aerospace Medicine Medicare: Medicare Enrolled Practice Location: 81 Flight Line Dr, Fredericksburg, VA 22405 Phone: 540-273-7993

Lawrence R Moter, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 12101 Carol Ln, Fredericksburg, VA 22407 Phone: 540-785-7778    Fax: 540-786-3318

Robert Leman Cohen, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3031 Plank Rd, Fredericksburg, VA 22401 Phone: 540-736-5043

News Archive

African leaders to form alliance to eliminate malaria deaths

African leaders, who are scheduled to meet in New York on Wednesday, are expected to launch an effort - the African Leaders Malaria Alliance (ALMA) - to eliminate all malaria deaths on the continent by 2015, the Daily Independent/allAfrica.com reports (Shokunbi, 9/22).

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Results from "Aviator," AbbVie's phase IIb clinical trial of its investigational direct-acting antivirals for the treatment of hepatitis C virus infection, continue to demonstrate high sustained viral response rates against genotype 1 HCV, across patient types.

HIV-positive status disclosure rates low in Ethiopia: Study

In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive status disclosure rates among men and women in Africa's second most populous country.

PAHO vaccines books wins major award

The Pan American Health Organization's publication, Vaccines: Preventing Disease and Protecting Health, has won an award from the Association of American Publishers in the medical science category.

Ardea Biosciences reports results of RDEA594 Phase 2a study for hyperuricemia and gout

Ardea Biosciences, Inc. announced additional positive results from the completed first cohort of an ongoing Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout.

Read more Medical News

› Verified 2 days ago